Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Daily oral PrEP
DRUG
2 trials
Sponsors
University of California, Los Angeles
, University of Washington
Conditions
HIV Infections
HIV Prevention
Pre-Exposure Prophylaxis
Sexually Transmitted Diseases, Bacterial
Phase 4
Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women
Completed
NCT02584140
University of California, Los Angeles
HIV Prevention
Start: 2016-05-31
End: 2019-06-14
Updated: 2021-07-08
Alignment of PrEP Use With HIV Risk in Young Women and Men
Completed
NCT04664998
University of Washington
HIV Infections, Pre-Exposure Prophylaxis, Sexually Transmitted Diseases, Bacterial
Start: 2018-05-01
End: 2023-12-10
Updated: 2025-06-17
Related Papers
The impact of intimate partner violence on PrEP adherence among U.S. Cisgender women at risk for HIV.
2024-05-31
1 citations
Pre-Exposure Prophylaxis Perspectives, Sociodemographic Characteristics, and HIV Risk Profiles of Cisgender Women Seeking and Initiating PrEP in a US Demonstration Project
AIDS Patient Care and STDs
2021-12-01
11 citations